The effect on oncology of the doctrine of Cartesian dualism is examined. It is argued that (1) this doctrine continues to exert a baneful (though unacknowledged) influence on the practice of oncology, (2) Descartes's doctrine of a mind/ body split is mistaken, and (3) mind and body (brain) are inextricably interwoven. A biopsychosocial model of disease is advocated. The role of psychooncology in healing the mind/ body split by focusing research attention on the patient is outlined.
Introduction
Plato's strictures apply not only to physicians in ancient Greece but with equal force to contemporary medical practice including oncology. The present article considers the principal reasons for the mind/body split, its influence on the treatment of cancer patients, and the role of psychooncology in attempting to heal this split.
The Mind/Body Split
There can be little doubt that the 17th-century philosopher René Descartes has exerted a powerful influence on science and medicine. He founded analytic geometry and contributed to the science of optics. He also advocated "methodical doubt," which remains a mainstay of philosophical thought. 2, 3 Less valuable was the argument he is reported to have made 4 that since humans have only one soul and only a single pineal gland, the soul must be located in that gland. Faulty logic aside, this speculation is, by today's standards, no more than a harmless diversion. The same could be said for his famous dictum "cogito ergo sum," which, to the present author's philosophically untutored mind, would seem to make more sense if reversed, that is, "I am therefore I think." Be that as it may, what has been definitely harmful is Descartes's sharp separation between mind and body. We owe to Descartes the concept, which is still prevalent, of mind and matter as two great, mutually exclusive, and mutually exhaustive divisions of the universe we inhabit. 5 In his own words, "It is certain that this 'me' (that is to say my soul by which I am what I am), is entirely and absolutely distinct from my body and can exist without it." 5 The huge influence of this French philosopher on medicine has been noted by medical historians (eg, Bynum 6 ). From Descartes's time onward, a belief in the mind (or soul) as an intangible nonphysical entity, distinct from the physical body, became the preeminent view of human reality in Western thought (Martin 7 ).
The mind/body split can be seen as a mind/brain split. Embedded in our culture is the perception of the mind as an immaterial entity with a life of its own, something that is more than just a brain. This common belief has been described memorably by the philosopher Gilbert Ryle 8 as "the myth of a ghost in the machine." It is obvious that mental (psychological) processes cannot occur in the absence of a brain. This incontrovertible fact was recognized some 2500 years ago by the most celebrated physician of antiquity. Hippocrates 9 wrote, And men ought to know that from nothing else but from the brain come joys, delights, laughter and sports, and sorrows, griefs, despondency and lamentations. And by this, in an especial manner, we acquire wisdom and knowledge, and see and hear, and know what are foul and what are fair, what are bad and what are good.
Hippocrates's remarkably prescient observation remains true today. Despite the efforts of so-called psychical researchers, there is no credible, reproducible evidence of a disembodied mind. Belief in the latter is based on ideology rather than on science. A rational view, advocated by a leading neuroscientist, 4 is to regard mind as "the evolving personal aspect of the physical brain as it develops and adapts throughout life."
Careful clinical observations (eg, Damasio 10 ), as well as compelling evidence from neuroscience, demonstrate that mind and body-far from being separate entities-are inextricably interwoven. Indeed, thanks to the latest technology in neuroscience, we are beginning to understand more clearly ways in which the brain and mind intersect (Pert 11 ; Gabbard 12 ). Nevertheless, Cartesian dualism persists. Its influence within medicine-although unacknowledged-has resulted, as a biologist in his critical review puts it, in the woeful neglect of the mind by modern medicine and the deep-seated skepticism about the role of psychological and emotional factors in disease ( Martin 7 ). Neglect of psychological factors is due not only to Cartesian dualism. In the 19th century, Virchow's discovery that diseases could be located in the body's cells and Koch's germ theory, which postulated that infectious diseases were caused by bacteria that when isolated, would reproduce the same disease in animals, became the foundation of the biochemical model of disease. This model has held sway ever since. It has undoubtedly produced great advances in our understanding of disease. The biomedical model is based on pathophysiology, molecular biology, and related sciences that adopt what has been called a "bottom-up" "upward causation" approach to the study of disease. Critics of the biomedical model refer to it as "reductionist," in the sense that it ignores the "topdown" contribution to disease, that is, the mind (psychological factors).
In a seminal paper, Engel 13 put forward compelling arguments, based on clinical evidence, that the biomedical model should be enlarged to take into account the influence of psychosocial factors on disease. Some critics have gone further, however, and advocated that the biomedical model should be abandoned altogether. In a challenging, closely reasoned series of papers, Foss [14] [15] [16] argued that "human disease is not deviation from normal structure, physiology, biochemistry, cellular and molecular biology . . . (but that) the patient's interior life is an independent prognostic variable in disease onset, progression and/or severity." He cited evidence for the well-documented effect of placebos to argue that "the subject's belief or expectation of what is happening, rather than what is actually happening, alters biological outcome." So far so good. But I part company with him when he argues that "biologically, there is no middle ground. Either the patient is only a biological mindless entity or the patient is a 'thinking mind-body'. One or the other." 17 This argument leads Foss to suggest that the biomedical model must be scrapped and replaced by a new "science of pathopsychophysiology with its own universal covering laws and associated mechanisms of action." This is a step too far, which would lead to the proverbial baby's being thrown out with the bath water. The overwhelming successes of the biomedical model so far guarantee that further important advances in our understanding of disease will follow, advances that would be lost were we to abandon that model. Foss's criticisms of the biomedical model are well founded, but his argument that this model cannot be modified and should be abandoned altogether is not persuasive.
Consequences of the Mind/Body Split
In the 21st century, the biomedical model remains necessary, but it is no longer sufficient. It has ignored the influence of the mind on the body. As a consequence, the role of psychological factors in the onset and progress of disease and in the effects of the disease and its treatment on the patient's quality of life have been largely ignored or minimized in medical education, research, and practice. Cartesian dualism can be seen clearly in one of the most common questions doctors ask themselves when considering a patient's symptoms, namely, "Is this organic or psychological?" instead of considering which specific biological, psychological, and social factors contribute to the etiology and progress of this patient's illness. Medical approaches still assume a persistent Cartesian dualism of mental and physical, psyche and soma, mind and brain. Clinically, an unfortunate result has been that treatment of disease has often been conducted with little thought for the patient suffering from the disease. Nowhere has this been more evident than in cancer treatment. A striking example can be seen in the unusually frank comments of one surgeon. After describing the breast as "a superficial, utilitarian appendage," he went on to say, Radical mastectomy has been reviled because of high alleged incidence of complications and disfigure-ment. The loss of the breast alone, whether by simple or radical mastectomy is said to have profound detrimental psychological influence on the patient. . . . If well-intentioned thorough investigations as to the attitudes and reactions of the patient prior to, and after the operation are conducted, undoubtedly evidence of psychologic trauma will frequently be manifest. Such evidence, however, will usually have been produced by the enquiry rather than disclosed by it. The adoption of a casual attitude by the doctor before the operation and throughout follow-up examinations will go a long way towards eliminating these untoward and unnecessary occurrences. 18 What patients feel when their emotional needs are ignored is conveyed in the following examples. A woman teacher with breast cancer said, I had a biopsy on Wednesday and was given the result on Friday. There were eighteen of us there for biopsy . . . curtains were drawn around beds and patients sat up in solitary fear as the team trooped around from bed to bed giving the news. In my case, the bed was at the bottom of the ward and I had a long time to wait, feeling more and more sick and terrified every moment. Eventually the team-about four doctors, two sisters, a secretary and a few hangers-onreached my bed and I was told, quite sympathetically, I think, that I had a growth and must have my breast removed as soon as possible. I feel very strongly that news like that should be given by one sympathetic doctor in private, preferably when the patient has a relative or friend with her. . . . I was to be admitted to hospital on Tuesday for the mastectomy on Wednesday. On Monday I was alone in the house and utterly wretched. I went down to my doctor's surgery. . . . I don't know what I wanted from him-some sort of comfort or reassurance-but it was obvious that he had nothing to give. He was embarrassed, muttered something about having it done as soon as possible and stood up to dismiss me almost immediately. I realised then that it would be useless to ever consult him for anything which wasn't entirely physical. . . . In hospital, there was no opportunity to talk about one's feelings about mastectomy-I think there should be-and when I got home I had to adjust as best I could. (B. George, personal communication, 1975) A physician with non-Hodgkin's lymphoma said, Today's oncologists need to be encouraged to derive feelings of self-esteem and career satisfaction from improving the quality as well as the quantity of the patient's existence. By addressing the emotional problems associated with chemotherapy they can diminish their patient's feelings of abandonment and rage and prevent the despair which patients suffer when made to feel as though they are the only ones having difficulty with therapy. . . . The central point regarding chemotherapy from the standpoint of the patient is that these powerful drugs interfered with body functions which most people take for granted, making me feel as though I had surrendered bodily control to a group of external agents. That helpless feeling, rather than any individual side-effect, was what occasioned the need for the greatest adjustment. 19 A man with Hodgkin's disease said, My experiences have taught me that adjusting to life with Hodgkin's disease has as much to do with emotional attitudes and communication as with physical states. . . . While doctors will still enquire "How do you feel?", it seems to me that increasing reliance on high technology diagnostic equipment has let to a decreasing emphasis on the importance of my reporting my body state. I came to resent this. 20 A woman with breast cancer said, I prefer a more enlightened form of medicine offering less treatment and more care. 21 A man with colorectal cancer stated, I'm sure the surgeon did his best and I can't say that he was ever unkind to me. He always asked how I was, whether I had any pain. But when I mentioned the way the (colostomy) bag made me feel, that I was frightened to go out any more and felt too embarrassed to sleep in the same bed as my wife, he just told me to see the stoma sister. (W. James, personal communication, 1981) The cited comments illustrate the feelings of many patients in the recent past. Throughout these comments, there is a common theme, namely, that the psychological state of these patients was ignored. This was not because oncologists were unkind. On the contrary, in my experience, oncology-with rare exceptions-tends to attract physicians who are caring and sympathetic. But the climate of opinion was such that attention was focused entirely on extirpating the cancer whatever the cost. As a consequence, extreme surgical procedures were carried out, such as hemipelvectomy, forequarter amputation, and extended radical mastectomy involving removal of the breast, skin, pectoral muscles, axillary and internal mammary lymph nodes, and-for good measure-a section of the rib cage. These surgical procedures, sometimes referred to as "heroic," bring to mind the comment made by the Duke of Wellington after the battle of Waterloo: "The next greatest misfortune to losing a battle is to win such a victory as this." Some surgeons recognized "the immense price paid by the patient for his cure from cancer" and recommended that far more emphasis be placed on the quality of life saved. 22 Such comments, however, were rare.
The psychosocial effects of such draconian operations were largely ignored in the medical literature: a clear example of the mind/body split. In addition, the diagnosis of cancer was kept from patients 23 and, instead, imparted to their relatives. This state of affairs, prevailing during the 1950s, 1960s, and early 1970s, led to the emergence of 2 new medical disciplines: palliative medicine and psychooncology. These disciplines have much in common, in particular, their emphasis on the alleviation of physical and psychological distress of patients with cancer.
Fortunately, the situation for patients has improved in the past 25 years. Advances in treatment (mainly combination chemotherapy and hormone therapy) have rendered unnecessary the drastic surgical procedures mentioned above and have prolonged the lives of patients with various cancers, thereby focusing attention on the quality of life. But with Cartesian dualism still alive and well, reports of patients' quality of life in cancer treatment trials have been largely confined to the presence or absence of physical symptoms; the psychological well-being of patients has been almost entirely ignored. It was this unfortunate situation that stimulated the development of psychooncology. Some salient contributions of this discipline to the study of patients with cancer are outlined below.
Bringing the Patient Back Into Oncology
Enlarging the biomedical model of disease to include psychosocial factors is, as argued earlier, imperative. A succinct description of such a biopsychosocial model has been provided by Lipowski 24 : (1) health and disease are considered more or less arbitrary defined states determined by biological, psychological, and social factors; (2) the relative importance of each set of factors will vary according to the specific disease and the individual patient, but the contribution of biological, psychological, and social factors should each be taken into account in considering etiology, diagnosis, prognosis, and prevention of any given disease; (3) finally and most important, adequate medical care requires treatment not only of the disease itself but of the patient who suffers from the disease.
Psychooncology, the study of patients who develop cancer, is based on this comprehensive, biopsychosocial model of disease. Accordingly, research in psychooncology can be grouped under the following headings:
1. psychosocial factors that may contribute to the etiology and progress of cancer; 2. psychobiological studies; 3. the psychosocial effects on patients and their families of cancers, various cancer treatments, and recently, genetic counseling and prophylactic surgery; 4. communication between patients and physicians; 5. the development and evaluation of psychotherapeutic programs designed to alleviate cancerrelated psychological distress and thereby improve the patients' quality (and possibly duration) of life.
A brief outline of research in each of these areas is given below. A detailed review is beyond the scope of the present article. Instead, I have selected some salient topics that give an indication of the nature and range of research in psychooncology.
Psychosocial Factors Contributing to Cancer
The most comprehensive review of this topic, a review that marked a significant milestone in psychooncology, was published by Fox. 25 More than 20 years later, it remains the best review in the field. Research in this area can be categorized as follows. 1 . Behavioral factors that contribute to the etiology of certain cancers include smoking tobacco, excessive alcohol consumption, diet, and excessive sun exposure. These factors have been extensively studied. [26] [27] [28] [29] [30] [31] [32] There remains, however, a large gap between, on one hand, what is known about the importance of these factors in the etiology of many cancers and, on the other, our striking inability to change such carcinogenic behavior at present. Clearly, further research is urgently required that would enable us to alter the social conditions favoring carcinogenic behavior and lead to the development of effective methods of psychological therapy for these behaviors. 2. The influence of states of mind (ie, psychological factors) on the promotion of cancer and on its subsequent progress. Research in this area is based on the following hypothesis: cancer is a multistep process; whatever the random mutation and other biological initiators of the cancer process, its further promotion and spread will depend in part on homeostatic controls that can be influenced by psychological factors through neurohormonal and immunological pathways. 33 This hypothesis is valuable in focusing the attention of researchers on the patient, stimulating studies on the following: (1) the influence of specific states of mind on etiology (promotion) and prognosis of certain cancers, (2) the effect of psychological therapy on duration of survival of patients, and (3) the biological pathways that mediate the posited effects of states of mind.
Controlled studies of several psychological factors preceding the onset of cancer have been reported, including stress and depression. With regard to stress, the majority of studies have found no relationship between the clinical onset of breast cancer and the recurrence of stressful events within the previous 5 years. 34 One research group reported a significant association between the diagnosis of colorectal cancer and stressful events in the previous 5 years. 35 Conflicting results have been reported concerning depression and the subsequent onset of cancer. 36 A major, currently insurmountable obstacle to studies of the relationship between psychological factors and the subsequent onset of cancer is that the time of the actual onset of the disease (as opposed to the clinical onset) remains unknown.
There is no such obstacle in studying prognostic psychological factors. In designing such prognostic studies, it is essential to obtain accurate data on biological prognostic factors, to have valid, reliable measures of psychological factors, and to achieve as complete a follow-up as possible. Which patients should be studied? On a priori grounds, psychological factors are more likely to influence prognosis in patients with cancers that have a variable course and in which immunological and/or hormonal factors play an important role, such as Hodgkin's disease; malignant melanoma; cancers of the breast, prostate, and kidney; and gynecological cancers. Prospective studies have examined the effect of social support, stress, depression, type-C behavior and coping style on disease outcome in patients with various cancers. Social support is variously defined in the literature. There is evidence from several prospective studies that social involvement and being married is significantly associated with increased survival in women with breast cancer, with the effect of marital status being greater in younger women. [37] [38] [39] Although stress per se is not associated with duration of survival, [40] [41] [42] an elegant study of women with cervical intraepithelial neoplasia demonstrated that stress combined with a coping style of hopelessness and pessimism was significantly associated with disease promotion to cervical carcinoma. 43 These results indicate that studies of stress (ie, the occurrence of adverse life events) should always include measures of coping style. This accords not only with research findings but also with common sense.
The study by Goodkin et al 43 points to the importance of hopelessness as a prognostic factor in cancers. Indeed, the majority of prospective studies of the effect of coping styles on disease outcome in patients with various cancers have reported that helplessness/ hopelessness is significantly associated with poor disease outcome (relapse, death) independently of disease stage or other biological prognostic factors. 44 Helplessness/hopelessness is associated with depression, but the direction of this association is not clear. Reported results regarding the prognostic signifi-cance of depression are inconsistent. This discrepancy is probably due to measures of depression that fail to distinguish between depressive illness and a depressivelike state of emotional distress found in patients with cancer. 45 People showing the type C behavior pattern rarely if ever express anger; they tend not to express other negative emotions such as anxiety, fear, or sadness; they are unassertive, cooperative, and appeasing; and they are overly concerned with meeting the needs of others and insufficiently engaged in meeting their own needs. 46 This behavior pattern has been posited both as a risk factor for cancer (for a review of these studies, see Gross 47 ) and as a prognostic factor. Temoshok et al 48 reported the type C behavior pattern to be significantly associated with thicker and more invasive malignant melanoma as well as with greater disease progression when controlling for known prognostic factors. 46, 49 
Psychobiological Studies
In the light of evidence that indicates that states of mind can have a significant-although moderateeffect on duration of survival in patients with certain cancers, the question that arises is, What are the psychobiological mechanisms that mediate this effect? Investigations of the neurohormonal and immunological mechanisms that could be involved have been reported in recent years. In this exceedingly complex area of research, the growing scientific discipline of psychoneuroimmunology (PNI) has particular heuristic value. PNI has begun to identify specific immune functions that are affected by psychological factors. [50] [51] [52] [53] Studies that are clinically relevant to oncology have also been reported. Fawzy et al 54 found that psychological therapy increased the percentage of natural killer cells and natural killer cell activity in patients with malignant melanoma. Walker et al 55, 56 reported that (1) anxiety and depression were significant prognostic indicators for clinical and pathological response to chemotherapy and (2) relaxation therapy with guided imagery was significantly associated with higher lymphokine-activated killer cell activity in women with breast cancer.
Psychosocial Effects of Cancer
Considerable research efforts have been devoted by psychooncologists and their clinical oncologist colleagues to documenting the psychosocial consequences of cancers and cancer treatments on patients and their families. Although the majority of patients learn to cope with their disease and the unpleasant side effects of surgery, chemotherapy, and radiotherapy, systematic studies have revealed that between 23% 57 and 47% 58 of patients develop clinically signifi-cant psychological disorders. The largest and most recent study reports a prevalence of 35%. 59 Moreover, a lengthy follow-up study of patients with Hodgkin's disease has shown that psychosocial problems may persist for years, even in the absence of disease. 60, 61 Apart from psychological symptoms, studies of social functioning have revealed cancer-related disturbances in marital and other close relationships and sexual dysfunction in patients and their families. [62] [63] [64] Studies such as these are not merely of academic interest. In highlighting specific cancer-related psychosocial disturbances, the studies have 2 clinically important functions: (1) They enable oncologists to base treatment decisions on their patient's quality of life as well as on duration of survival, and (2) these studies provide a basis for the development of psychological therapy designed to improve the patients' quality of life.
Doctor-Patient Communication
Listening carefully to patients and providing accurate, clear, jargon-free information that is sensitively imparted are essential components of good medical practice. Nowhere is this more important than in oncology. Good communication is necessary at every stage of the treatment of patients from diagnosis of cancer to palliative care, as well as during genetic counseling of family members. Deficiencies in communication resulting in patients' being misinformed about their cancer have been identified, [65] [66] [67] and the preference of most patients to be well-informed about diagnosis, prognosis, therapeutic options, and side effects has been documented. 68 Programs to teach oncologists and other health care professionals communication skills have been developed 69, 70 and are being evaluated.
Psychotherapy for Patients With Cancer

Effect on Quality of Life
Advances in treatment of cancers have led, in many cases, to prolonged survival; hence, the quality of life of cancer survivors has become increasingly important. Having documented cancer-related psychosocial morbidity, psychooncologists have gone on to develop methods of psychological therapy aimed at reducing such morbidity, thereby improving patients' quality of life. Several methods of individual and group psychotherapy have been adopted for use with cancer patients, principally cognitive behavior therapy, 61 psychoeducational therapy, 71 and supportive-expressive group therapy. 72 These broad categories are neither sharply defined or mutually exclusive. In practice, clinicians may combine elements from more than one model.
Meta-analyses of randomized controlled trials of psychological therapy (predominantly cognitive behavior therapy) for patients with various cancers have shown that therapy results in a significant reduction in clinical anxiety. 73, 74 Clinical experience suggests that the effect of psychotherapy is greatest in those cases in which patients are experiencing marked psychological distress; hence, psychotherapy should be offered to those individuals. Meyer and Mark 73 found that the beneficial effects of psychotherapy included psychological adjustment, functional adjustment (eg, returning to work), and anticipatory nausea due to chemotherapy. Our own randomized trials of cognitive behavior therapy for patients with various cancers demonstrated significant reduction of anxiety and feelings of hopelessness with a corresponding increase in fighting spirit (an active coping response), with cognitive therapy being superior to counseling in these respects. 75 
Effect on Survival
The first randomized trial was conducted by Spiegel et al, 75 who reported that women with metastatic breast cancer who received group supportiveexpressive therapy lived for an average of 18 months longer than did women in the control group. Since then, several other randomized trials have been conducted, with contradictory findings. 56, [76] [77] [78] It should be noted that these were not replication studies of Spiegel's original investigation. One replication study has been published; Goodwin et al 79 reported that group therapy had no effect on survival. The effect of any kind of psychological therapy on duration of survival remains an open question. A thoughtful and challenging contribution to the intriguing question has been made recently by Cunningham et al, 80 who presented evidence that the degree of involvement in psychotherapy may have a bearing on survival.
Conclusions
By focusing research attention on the person who develops cancer, psychooncology has helped to bring the patient back into oncology. Cancer-related psychosocial morbidity has been documented and methods of psychological therapy developed that are effective in reducing such morbidity. Evidence has accrued from prospective studies that the coping style of hopelessness is a significant prognostic factor, independent of biological prognostic factors. That a state of mind appears to have an effect (albeit a modest one) on disease outcome flies in the face of Cartesian dualism and reinforces the concept of mind and body as inextricably linked. The psychobiological pathways have yet to be identified. In the meantime, it behooves all of us who are involved in the clinical care of patients with cancer to keep in mind Hippocrates's dictum: "The patient must combat the disease along with the physician."
